What Can You Take Instead of Amoxicillin?

Several effective antibiotics can replace amoxicillin, but the right substitute depends on why you need one and what infection you are treating. Amoxicillin sits at the top of prescribing guidelines for good reason: it is cheap, well-tolerated, and effective against a wide range of common bacteria. Swapping it out is not a simple one-for-one trade, because different alternatives carry different side-effect profiles, different spectrums of bacterial coverage, and meaningfully different risks of complications like gut infections.

Why You Might Need a Substitute

People end up looking for amoxicillin alternatives for a few distinct reasons, and each one changes the conversation. The most common is a reported penicillin allergy. Roughly eight to ten percent of the U.S. population carries a documented penicillin allergy label, and that number climbs even higher among hospitalized patients.¹ A second reason is drug shortages. During the 2022 amoxicillin shortage in the United States, prescribing of amoxicillin suspension at pediatric hospitals dropped by about 31%, forcing clinicians to reach for broader-spectrum antibiotics instead.² Other reasons include bacterial resistance to amoxicillin in a particular infection, intolerable side effects like severe diarrhea, or a need to treat a pathogen that amoxicillin simply does not cover well.

Your clinician’s choice of alternative will hinge on the specific infection. Amoxicillin is prescribed for a wide range of conditions including ear infections, sinusitis, strep throat, community-acquired pneumonia, urinary tract infections, and skin infections.³ An alternative that works well for a sinus infection may be a poor choice for a urinary tract infection, so there is no universal drop-in replacement.

The Penicillin Allergy Question Is Worth Revisiting

Before exploring alternatives, it is worth addressing one of the most consequential findings in allergy medicine: the overwhelming majority of people who carry a penicillin allergy label are not actually allergic. More than 90% of patients with a documented penicillin allergy can safely take penicillins and related antibiotics after formal evaluation.¹ Many of these labels date back to childhood reactions that were likely viral rashes misidentified as drug allergies, or mild side effects like nausea that do not constitute a true allergy.

Getting that label removed through allergy testing or a supervised oral challenge is one of the most impactful things you can do for your long-term health care. Carrying an inaccurate penicillin allergy label pushes prescribers toward broader-spectrum antibiotics that are more expensive, more likely to cause side effects, and more likely to drive antibiotic resistance.⁴ If you have never had formal allergy testing and your “allergy” is based on a distant memory of a childhood rash, bring it up at your next visit. Getting cleared could open the door back to amoxicillin itself.

Cephalosporins

Cephalosporins are the closest cousins of amoxicillin in terms of how they work, and they are among the most commonly chosen alternatives. Drugs like cephalexin (a first-generation cephalosporin) and cefdinir or cefuroxime (later-generation options) cover many of the same bacteria. For straightforward infections like strep throat, skin infections, or uncomplicated urinary tract infections, a cephalosporin is often the first place a prescriber looks when amoxicillin is off the table.

The lingering concern about cephalosporins in people with penicillin allergies comes from older estimates that put the cross-reactivity rate alarmingly high. More recent research has clarified the picture: cross-reactivity depends on the specific chemical structure shared between the penicillin and the cephalosporin. The R1 side chain on the molecule is the key driver of cross-reactions, and the risk is highest with first- and second-generation cephalosporins that share a similar side chain with amoxicillin or ampicillin.⁵ Third-generation cephalosporins like cefdinir or cefixime have structurally different side chains and carry a much lower risk.

In an Australian study of patients labeled with cephalosporin allergies who also had penicillin allergy labels, nearly 88% of those who underwent a supervised penicillin challenge tolerated it and had their allergy label removed.⁶ The practical takeaway: if your penicillin allergy was mild or uncertain, your clinician may feel comfortable prescribing a cephalosporin whose side chain differs from amoxicillin’s. If your reaction involved anaphylaxis or a severe immune response, the decision requires more caution and likely allergy consultation.

Macrolides Like Azithromycin

Azithromycin is probably the alternative most people have heard of, and for certain infections it works well. It belongs to the macrolide class and has no chemical resemblance to penicillins, which means there is no cross-reactivity concern. It is widely used for respiratory tract infections, ear infections in children, and strep throat when a penicillin is off the table. Its dosing convenience is a real advantage: a typical course is three to five days, sometimes just a single dose for certain infections, compared to the seven-to-ten-day courses typical of amoxicillin.

The catch is resistance. Macrolide resistance has been climbing globally for decades. Across 30 years of data, about 6% of specimens globally show azithromycin resistance, with nearly a third of countries reporting resistance rates above 5%.⁷ Those numbers represent a global average and vary significantly by region. In some areas, particularly parts of Asia and Southern Europe, local resistance rates are far higher, making macrolides unreliable for certain infections.

This is not just a theoretical concern about future resistance. Rising macrolide resistance among common pathogens like certain Campylobacter species, Salmonella, and streptococcal strains has real consequences now.⁸ Azithromycin still works well in many settings, but it is not the universal safety net it once was, and your prescriber may order a culture first to make sure the bacteria involved are susceptible.

Clindamycin for Dental and Soft Tissue Infections

Clindamycin occupies a specific niche as an amoxicillin alternative, and it shows up most often in dental infections and soft tissue infections like cellulitis. It penetrates bone well, which makes it particularly useful for jaw infections, dental abscesses, and similar conditions where amoxicillin would normally be the first choice. For penicillin-allergic patients with dental infections, a combination of clindamycin and metronidazole is a standard empiric option.⁹

Lab studies have shown that clindamycin and amoxicillin are comparably effective at inhibiting bacteria commonly found in the mouth, including Streptococcus sanguinis, and both significantly outperform metronidazole alone against that organism.¹⁰ Clindamycin also works as an alternative for pediatric dental infections when penicillin is not an option.¹¹

Clindamycin does come with a serious caveat, though, which the next section addresses in more detail: it carries one of the highest risks of any oral antibiotic for triggering Clostridioides difficile infection, a potentially severe gut infection.

Trimethoprim-Sulfamethoxazole

Commonly known by the brand name Bactrim or by its abbreviation TMP-SMX, this combination antibiotic serves as an alternative to amoxicillin for several conditions. It has been used for decades as a second-line option for urinary tract infections, sinus infections, ear infections in children, and flare-ups of chronic bronchitis, particularly in penicillin-allergic patients.¹² In children with ear infections, it has long been considered a go-to alternative when the infection is caused by bacteria that produce enzymes breaking down penicillin-type drugs.¹³

TMP-SMX works through a completely different mechanism than penicillins, so there is no cross-reactivity. It does have its own side-effect profile to watch for: it can cause rashes, sensitivity to sunlight, and rarely more serious reactions in people with sulfa allergies. It is generally well tolerated in short courses, but it is not a good choice for strep throat or most skin infections where amoxicillin would typically be used because its coverage of streptococcal species is less reliable.

Why Fluoroquinolones Are Usually a Last Resort

Fluoroquinolones like ciprofloxacin, levofloxacin, and moxifloxacin are powerful broad-spectrum antibiotics that technically cover many of the same infections as amoxicillin. You will occasionally see them prescribed for sinusitis, urinary tract infections, or pneumonia. However, they carry regulatory black-box warnings for serious side effects including tendon rupture, nerve damage, and neuropsychiatric reactions.

A large pharmacovigilance analysis of nearly 96,000 individual case safety reports found drug-specific patterns of neuropsychiatric adverse reactions among the three most common fluoroquinolones. Peripheral neuropathy was the strongest neurological signal for levofloxacin and moxifloxacin, while ciprofloxacin showed stronger associations with central nervous system effects. Psychiatric side effects varied by drug, with anxiety predominating for ciprofloxacin and moxifloxacin and insomnia for levofloxacin.¹⁴

For a routine ear infection or sinus infection where amoxicillin would have been the first choice, the risk-benefit calculation rarely favors a fluoroquinolone. These drugs remain important for more serious infections, particularly complicated urinary tract infections and certain types of pneumonia, but prescribers generally exhaust other alternatives before reaching for them.

The Hidden Cost of Switching: C. Diff Risk

One of the least-discussed consequences of substituting amoxicillin with a different antibiotic is the varying risk of developing a Clostridioides difficile infection, a gut infection that causes severe diarrhea and can be life-threatening in vulnerable patients. Not all antibiotics carry the same C. diff risk, and the differences are dramatic.

A case-control study comparing community-associated C. diff risk across different antibiotics found that clindamycin carried the highest risk, with an odds ratio above 25. Later-generation cephalosporins like cefixime, cefdinir, cefuroxime, and cefpodoxime, along with amoxicillin-clavulanate, had odds ratios ranging from roughly 8.5 to 12. Fluoroquinolones like ciprofloxacin and moxifloxacin fell in the middle tier with odds ratios between about 4 and 7. First-generation cephalosporins, levofloxacin, and TMP-SMX had lower but still elevated odds ratios between roughly 2 and 3.5. Macrolides carried one of the lowest elevated risks, with odds ratios under 2. Doxycycline and tetracycline showed no statistically significant increase at all, and minocycline actually appeared protective.¹⁵

This data is worth knowing because it means the choice of amoxicillin alternative is not just about whether it kills the target bacteria. Clindamycin, for example, is excellent for dental infections, but its outsized C. diff risk makes it a poor choice for situations where a safer alternative exists. Your prescriber weighs these competing risks, and it is reasonable to ask about them.

Alternatives for H. Pylori Eradication

One specific clinical scenario deserves its own discussion: Helicobacter pylori, the bacterium that causes stomach ulcers and chronic gastritis. Standard eradication regimens rely heavily on amoxicillin as a cornerstone. If you cannot take amoxicillin, the treatment looks quite different.

For penicillin-allergic patients, bismuth-based quadruple therapy has demonstrated strong eradication rates, typically ranging from 88% to 97%. Newer vonoprazan-based regimens paired with clarithromycin and metronidazole have also shown excellent results and tend to be better tolerated, requiring fewer daily pills.¹⁶ A systematic review of penicillin-free H. pylori treatments confirmed that bismuth-based and quinolone-based therapies emerged as the most effective alternatives overall, with certain quinolone-based regimens exceeding 90% eradication rates.¹⁷

If first-line penicillin-free regimens fail, options narrow but do not disappear. Levofloxacin-based regimens and susceptibility-guided therapy, where the bacteria are cultured and tested against specific antibiotics, can guide rescue treatment. One combination to avoid: clarithromycin with rifabutin, which has shown low eradication rates and frequent side effects.¹⁶

What Shortages Have Taught Us

Amoxicillin shortages are not hypothetical. They have happened repeatedly in recent years, and data from those episodes reveals an uncomfortable pattern. When amoxicillin supply drops, prescribers consistently shift toward broader-spectrum agents rather than equally narrow ones. In a Japanese study of pediatric clinics during a chronic amoxicillin shortage, prescriptions for the narrowest-spectrum antibiotics dropped from about 54% to 47% of all antibiotic prescriptions, while broader-spectrum “Watch” category antibiotics climbed from about 46% to 53%. Third-generation cephalosporin use specifically rose from about 19% to 25%.¹⁸

This matters because broad-spectrum antibiotics kill a wider range of bacteria, including beneficial ones in the gut, and contribute more to antibiotic resistance. A U.S. study of seven pediatric hospitals during the 2022 shortage documented the same trend: prescribers moved to amoxicillin tablets when suspension was unavailable, but also significantly increased broad-spectrum antibiotic use.² The lesson from these shortages is that having explicit backup guidelines matters, both for individual clinicians and for health systems. Without a standardized plan, the default response is to reach for something stronger, which is not always better.

Palatability Matters More Than You Think

For children who need liquid antibiotics, taste is not a trivial concern. A medication that a child spits out or refuses after two days is a medication that does not work, no matter how well it kills bacteria in a lab. Amoxicillin suspension is widely considered one of the most palatable pediatric antibiotics. In a survey of general practitioners and pharmacists, amoxicillin was rated the most palatable liquid antibiotic for children by a majority of both groups, with cefaclor a distant second.¹⁹

On the opposite end of the spectrum, clarithromycin and flucloxacillin were identified as the most unpalatable antibiotics by both professions. The flavor of antibiotic suspensions directly influences real prescribing decisions and, more critically, whether a child actually finishes the full course.²⁰ Different formulations of the same drug can taste quite different, and some have been perceived as far more acceptable than others.²¹

If your child has been switched from amoxicillin to an alternative like clarithromycin or cefdinir, it is worth asking the pharmacist about mixing strategies, flavoring options, or whether a chewable tablet formulation exists. The best antibiotic is one that actually gets taken as prescribed.

When You Can Skip Antibiotics Entirely

For some of the infections where amoxicillin is commonly prescribed, the honest answer to “what can I take instead?” may be nothing at all. Many sinus infections, mild ear infections in older children, and cases of acute bronchitis are caused by viruses and will resolve on their own. Delayed prescribing, where a clinician writes you an antibiotic prescription but asks you to wait a few days to see if symptoms improve before filling it, has been studied as a strategy to reduce unnecessary antibiotic use. In one prospective study of this approach in primary care, about 40% of patients given a delayed prescription never filled it at all, and most of those who did not fill it recovered without antibiotics.²²

This does not apply to every situation. Strep throat, confirmed bacterial pneumonia, urinary tract infections, and dental abscesses need antibiotics. But if your clinician suspects a viral illness and suggests watchful waiting, that is not substandard care. It is consistent with guidelines that aim to preserve the antibiotics we have, including amoxicillin, for when they are genuinely needed.

Emerging Resistance and the Shrinking Menu

One reason this whole topic matters more than it used to is that antibiotic resistance is steadily shrinking the menu of reliable options. Macrolide resistance in Campylobacter species, a common cause of bacterial gastroenteritis, has risen to the point where researchers are actively searching for oral alternatives. A study testing Campylobacter isolates that were resistant to both azithromycin and ciprofloxacin found that over 94% of those isolates were also resistant to clindamycin and about 69% were resistant to ampicillin-sulbactam. Only amoxicillin-clavulanate retained good activity, with just 2.6% resistance, leading the authors to suggest it deserves further evaluation as a treatment for Campylobacter gut infections.²³

The pattern is a familiar one in infectious disease: the very alternatives people reach for when amoxicillin is unavailable are themselves becoming less effective against certain organisms. This is a cycle driven partly by the overuse of those broader-spectrum alternatives during shortages and in patients carrying inaccurate penicillin allergy labels. Each unnecessary course of a fluoroquinolone or third-generation cephalosporin applies selective pressure that nudges bacteria toward resistance. Keeping amoxicillin and other narrow-spectrum penicillins in the game, including by removing inaccurate allergy labels and managing shortages thoughtfully, is part of the longer-term strategy to make sure alternatives remain available when they are truly needed.

1
PubMed Central. Penicillin Allergy Delabeling Can Decrease Antibiotic Resistance, Reduce Costs, and Optimize Patient Outcomes
2
PubMed Central. Alternative Antibiotic Selections During the 2022 Amoxicillin Shortage in the United States
3
Pexacy International Journal of Pharmaceutical Science. What Can You Take Instead of Amoxicillin – Section: Therapeutic Indications
4
PubMed. Lessons Learned: Approaches to Delabeling Penicillin Allergy-A Clinical Management Review of Population-Level Strategies
5
PubMed. The use of cephalosporins in penicillin-allergic patients: a literature review
6
PubMed Central. Cephalosporin allergy: R1 side-chain and penicillin cross-reactivity patterns in an Australian cohort
7
PubMed Central. Global status of Azithromycin and Erythromycin Resistance Rates in Neisseria gonorrhoeae: A Systematic Review and Meta-analysis
8
International Journal of Pharmaceutical Sciences. A Review of Azithromycin Resistance: Emerging Trends and Clinical Implications
9
PubMed Central. Antimicrobial management of dental infections: Updated review
10
Journal of Indonesian Dental Association. The Comparison of Metronidazole, Clindamycin, and Amoxicillin Againts Streptococcus sanguinis
11
Bangladesh Journal of Medical Science. Comparative Study of Different Antibiotic Regimens in Managing Paediatric Dental Infections
12
JAMA Internal Medicine. Trimethoprim-Sulfamethoxazole Revisited
13
PubMed. Drug therapy reviews: trimethoprim-sulfamethoxazole
14
MDPI / Pharmaceuticals. An Updated 16-Year Pharmacovigilance Analysis of Neuropsychiatric Safety Profiles of Ciprofloxacin, Levofloxacin, and Moxifloxacin Using FAERS Data
15
PubMed Central. Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case–Control Study
16
PubMed Central. Treatment of Helicobacter pylori Infection in Patients with Penicillin Allergy
17
PubMed Central. Clinical Effectiveness of Penicillin-Free Therapies in First-Line and Rescue Treatments for Helicobacter pylori: A Systematic Review
18
PubMed. Chronic amoxicillin shortage led to alternative broad-spectrum antimicrobial use in pediatric clinics
19
Family Practice. The impact of drug palatability on prescribing and dispensing of antibiotic formulations for paediatric patients: a cross-sectional survey of general practitioners and pharmacists
20
PubMed Central. Taste Perceptions of Common Pediatric Antibiotic Suspensions and Associated Prescribing Patterns in Medical Residents
21
PubMed Central. Palatability of liquid anti-infectives: clinician and student perceptions and practice outcomes
22
PubMed Central. Implementation of the delayed antibiotic prescribing strategy. Prospective observation study in primary care
23
PubMed Central. Phenotypic Resistance of Campylobacter Isolates to an Extended Panel of Antibiotics